Manage Your Liver
Q:

Blood Test Report :: YHK improves ALT level and liver function for hepatitis C cirrhosis patient

Blood Test Report :: YHK improves ALT level and liver function for hepatitis C cirrhosis patient
A:

Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.

 

YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to help the patient to recover and protect their liver function. [1][2][3] We can measure the level of liver cells damage by the ALT enzymes indicator found in liver function test. [4] When ALT level is high, it means that the liver cells and liver damage is more severe, on the other hand, if ALT is low and within the normal range, it means that the liver health and liver function is healthy. [5]

 

Here is a regular YHK users' (Age: 75) blood test report who has hepatitis C cirrhosis. The report shows the ALT level before and after using YHK. On 2013-08-28, the patients ALT level is 262, on the blood test shown on the 2013-09-23 the ALT level drop within normal range of 45. The ALT level has been normalised within less then 30 days. 

 

Since 2013, this patients has continue to use YHK as the main protection method for her hepatitis C and cirrhosis problem, and the patient’s ALT level has remain stable. The latest blood test report shows a ALT level of 29.

SEbloodtest1

Blood test result before and after using YHK. ALT 262 went down to 45 within 30 days.

SEbloodtest2

Recent blood test shows ALT level maintain normal at 29.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us